AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8531545 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyronaridine 32 mg/kg, orally divided over 3 days
Number of subjects: 96
Study 8531545 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine 25 mg/kg, orally divided over 3 days
Number of subjects: 96
Study 1857645 — intervention group
Group type: EXPERIMENTAL
Intervention: Injections in the abdomen
Number of subjects: 101
Study 1857645 — intervention group
Group type: COMPARATOR
Intervention: Injections in the thigh
Number of subjects: 101
Study 1857645 — intervention group
Group type: COMPARATOR
Intervention: Injections in the arm
Number of subjects: 101
Study 6418506 — intervention group
Group type: EXPERIMENTAL
Intervention: saline lavage solutions similar to plasma
Number of subjects: 64
Study 6418506 — intervention group
Group type: EXPERIMENTAL
Intervention: mannitol solution
Number of subjects: 64
Study 6418506 — intervention group
Group type: EXPERIMENTAL
Intervention: hypertonic salt and mannitol solution (415 mosmol/l)
Number of subjects: 64
Study 6418506 — intervention group
Group type: EXPERIMENTAL
Intervention: isotonic saline mannitol solution with 105 mmol/l sodium, 93 mmol/l chloride, 10 mmol/l potassium and 22 mmol/l bicarbonate as well as 70 mmol/l mannitol (or 70 mmol/l polyethylene glycol)
Number of subjects: 64
Study 29444538 — intervention group
Group type: EXPERIMENTAL
Intervention: Judo-specific resistance training program using a judo ergometer system (PTJ)
Number of subjects: 24
Study 29444538 — intervention group
Group type: COMPARATOR
Intervention: Traditional resistance training regime using a partner (PTP)
Number of subjects: 24
Study 27111089 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept (125 mg every week)
Number of subjects: 646
Study 27111089 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab (40 mg every 2 weeks)
Number of subjects: 646
Study 25768709 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling + Occlusal Splints (Group 2)
Number of subjects: 60
Study 25768709 — intervention group
Group type: COMPARATOR
Intervention: Counselling (Group 1)
Number of subjects: 60
Study 23063624 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based functional exercises (twice-weekly 60-minute sessions for 6 months)
Number of subjects: 110
Study 23063624 — intervention group
Group type: COMPARATOR
Intervention: Advice to stay active (control group)
Number of subjects: 110
Study 20119976 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy
Number of subjects: 34
Study 20119976 — intervention group
Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 34
Study 20119976 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 34
Study 18661191 — intervention group
Group type: EXPERIMENTAL
Intervention: General internists providing primary care for adults with cystic fibrosis (CF)
Number of subjects: 1288
Study 18661191 — intervention group
Group type: EXPERIMENTAL
Intervention: General internists providing primary care for adults with sickle cell disease (SCD)
Number of subjects: 1288
Study 18661191 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatricians providing primary care for adults with cystic fibrosis (CF)
Number of subjects: 1288
Study 18661191 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatricians providing primary care for adults with sickle cell disease (SCD)
Number of subjects: 1288
Study 17242102 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg IV
Number of subjects: 129
Study 17242102 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg IV
Number of subjects: 129
Study 17242102 — intervention group
Group type: COMPARATOR
Intervention: Saline IV
Number of subjects: 129
Study 12562649 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (ICT) and adjuvant chemotherapy (ACT) every 2 weeks with granulocyte-macrophage colony-stimulating factor (GM-CSF) support (arm B, 'dose-dense treatment')
Number of subjects: 150
Study 12562649 — intervention group
Group type: COMPARATOR
Intervention: Induction chemotherapy (ICT) and adjuvant chemotherapy (ACT) every 3 weeks (arm A, 'standard treatment')
Number of subjects: 150
Study 12562649 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms received three courses of CEF followed by local therapy and three courses of CEF alternated with three courses of CMF.
Number of subjects: 150
Study 12562649 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose intensity of chemotherapy in arm B
Number of subjects: 150
Study 12562649 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of treatment in arm B
Number of subjects: 150
Study 12562649 — intervention group
Group type: COMPARATOR
Intervention: Duration of treatment in arm A
Number of subjects: 150
Study 10880550 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel plus supportive care
Number of subjects: 157
Study 10880550 — intervention group
Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 157
Study 8838831 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition (TEN)
Number of subjects: 34
Study 8838831 — intervention group
Group type: COMPARATOR
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 34
Study 1296898 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands-on foot care teaching/learning approach
Number of subjects: 0
Study 1296898 — intervention group
Group type: COMPARATOR
Intervention: Lecture presentation on foot care (Control)
Number of subjects: 0
Study 6372986 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp hypothermia
Number of subjects: 26
Study 6372986 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (Control)
Number of subjects: 26
Study 31232991 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD/CAM with drilling guiding templates and pre-bent titanium plates
Number of subjects: 24
Study 31232991 — intervention group
Group type: COMPARATOR
Intervention: CAD/CAM occlusal splints only
Number of subjects: 24
Study 29966130 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional training and lifestyle exercise intervention for 12 months
Number of subjects: 141
Study 29966130 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 141
Study 26675765 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation at 60 μg/d
Number of subjects: 227
Study 26675765 — intervention group
Group type: COMPARATOR
Intervention: No supplementation
Number of subjects: 227
Study 24648722 — intervention group
Group type: EXPERIMENTAL
Intervention: Excessive daytime sleepiness (EDS) defined by Epworth Sleepiness Scale (cutoff score ≥10)
Number of subjects: 1058
Study 24648722 — intervention group
Group type: EXPERIMENTAL
Intervention: Excessive daytime sleepiness (EDS)
Number of subjects: 1058
Study 22245713 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention to improve opioid compliance in high-risk group
Number of subjects: 62
Study 22245713 — intervention group
Group type: COMPARATOR
Intervention: High-risk control group
Number of subjects: 62
Study 19085680 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepregnancy BMI
Number of subjects: 841
Study 19085680 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepregnancy BMI (after removing large-for-gestational-age infants)
Number of subjects: 841
Study 19085680 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight gain
Number of subjects: 841
Study 17901735 — intervention group
Group type: EXPERIMENTAL
Intervention: liposome polyvinyl‐pyrrolidone‐iodine (PVP‐I) hydrogel
Number of subjects: 43
Study 17901735 — intervention group
Group type: COMPARATOR
Intervention: silver‐sulfadiazine cream
Number of subjects: 43
Study 15228362 — intervention group
Group type: EXPERIMENTAL
Intervention: NPT strategy using naphthoquinone with physiological thiols for measuring plasma thiol concentrations
Number of subjects: 0
Study 15228362 — intervention group
Group type: COMPARATOR
Intervention: Standard techniques for corroborating results
Number of subjects: 0
Study 12407041 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 micro g desogestrel with testosterone pellets
Number of subjects: 31
Study 12407041 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 micro g desogestrel with testosterone pellets
Number of subjects: 31
Study 12407041 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 micro g and 300 micro g desogestrel with testosterone pellets
Number of subjects: 31
Study 12407041 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of oral desogestrel with depot testosterone
Number of subjects: 31
Study 9696231 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of BAK protein by immunohistochemical and immunoblot analyses
Number of subjects: 0
Study 9696231 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoblot analysis
Number of subjects: 0
Study 9696231 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of apoptosis by in situ DNA end-labeling
Number of subjects: 0
Study 7857733 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg ramipril
Number of subjects: 38
Study 7857733 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg ramipril
Number of subjects: 38
Study 7857733 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 2806622 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium B (2% UltroSer G)
Number of subjects: 141
Study 2806622 — intervention group
Group type: COMPARATOR
Intervention: Medium A (10% human fetal cord serum)
Number of subjects: 141
Study 785107 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapleural BCG vaccine administered in a single postoperative dose
Number of subjects: 38
Study 785107 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 38
Study 31494545 — intervention group
Group type: EXPERIMENTAL
Intervention: Deterministic algorithms for maximum consensus estimation
Number of subjects: 0
Study 31605198 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent energy restriction (IER) diet: 2600 kJ for two days/week.
Number of subjects: 197
Study 31605198 — intervention group
Group type: COMPARATOR
Intervention: Continuous energy restriction (CER) diet: 2100 kJ/day below estimated requirements.
Number of subjects: 197
Study 31605198 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IER and CER groups.
Number of subjects: 197
Study 30876922 — intervention group
Group type: EXPERIMENTAL
Intervention: Dispatcher assistance (DA+)
Number of subjects: 412
Study 30876922 — intervention group
Group type: COMPARATOR
Intervention: No dispatcher assistance (DA-)
Number of subjects: 412
Study 28583140 — intervention group
Group type: EXPERIMENTAL
Intervention: Single fresh blastocyst transfer
Number of subjects: 4
Study 28583140 — intervention group
Group type: COMPARATOR
Intervention: Single frozen blastocyst transfer
Number of subjects: 4
Study 25833335 — intervention group
Group type: EXPERIMENTAL
Intervention: Telegenetics (via live videoconferencing)
Number of subjects: 162
Study 25833335 — intervention group
Group type: COMPARATOR
Intervention: In-person CGC
Number of subjects: 162
Study 25833335 — intervention group
Group type: EXPERIMENTAL
Intervention: Telegenetics
Number of subjects: 162
Study 24132976 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU vitamin D3, 2 times during the study)
Number of subjects: 54
Study 24132976 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 54
Study 24132976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 21896264 — intervention group
Group type: EXPERIMENTAL
Intervention: Six sessions of smoking cessation telephone support delivered by bilingual psychologists (n=213)
Number of subjects: 407
Study 21896264 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=194)
Number of subjects: 407
Study 19675378 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT)
Number of subjects: 30
Study 19675378 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE)
Number of subjects: 30
Study 19675378 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 17668979 — intervention group
Group type: EXPERIMENTAL
Intervention: Subantimicrobial dose doxycycline (SDD; 20 mg twice a day)
Number of subjects: 128
Study 17668979 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 14705234 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 37.5 mg/acetaminophen 325 mg (tramadol/APAP)
Number of subjects: 306
Study 14705234 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 306
Study 11145764 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic waveform in group 1
Number of subjects: 118
Study 11145764 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic waveform in group 2
Number of subjects: 118
Study 11145764 — intervention group
Group type: EXPERIMENTAL
Intervention: Monophasic waveform in group 1
Number of subjects: 118
Study 11145764 — intervention group
Group type: EXPERIMENTAL
Intervention: Monophasic waveform in group 2
Number of subjects: 118
Study 9699102 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive therapeutic suggestions during neurolept-anaesthesia
Number of subjects: 100
Study 9699102 — intervention group
Group type: COMPARATOR
Intervention: Empty tape (control group)
Number of subjects: 100
Study 7989521 — intervention group
Group type: EXPERIMENTAL
Intervention: Human menopausal gonadotrophin (HMG)
Number of subjects: 0
Study 7989521 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene/HMG
Number of subjects: 0
Study 2729930 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefmetazole (2 g intravenously)
Number of subjects: 16
Study 2729930 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefmetazole with probenecid pretreatment (1 g orally)
Number of subjects: 16
Study 2729930 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin (2 g intravenously)
Number of subjects: 16
Study 31277120 — intervention group
Group type: EXPERIMENTAL
Intervention: Eculizumab treatment
Number of subjects: 17
Study 31277120 — intervention group
Group type: COMPARATOR
Intervention: Control (no eculizumab treatment)
Number of subjects: 17
Study 28592294 — intervention group
Group type: EXPERIMENTAL
Intervention: Calf raising and walking exercise
Number of subjects: 28
Study 26381229 — intervention group
Group type: EXPERIMENTAL
Intervention: output‐oriented individual intervention and articulation practice home program
Number of subjects: 65
Study 26381229 — intervention group
Group type: EXPERIMENTAL
Intervention: output‐oriented individual intervention and dialogic reading home program
Number of subjects: 65
Study 26381229 — intervention group
Group type: EXPERIMENTAL
Intervention: input‐oriented individual intervention and articulation practice home program
Number of subjects: 65
Study 26381229 — intervention group
Group type: EXPERIMENTAL
Intervention: input‐oriented individual intervention and dialogic reading home program
Number of subjects: 65
Study 23784010 — intervention group
Group type: EXPERIMENTAL
Intervention: BRCA Gist intelligent tutoring system
Number of subjects: 0
Study 23784010 — intervention group
Group type: EXPERIMENTAL
Intervention: National Cancer Institute (NCI) Web pages
Number of subjects: 0
Study 23784010 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 22120032 — intervention group
Group type: EXPERIMENTAL
Intervention: Touch contact (TC)
Number of subjects: 62
Study 22120032 — intervention group
Group type: COMPARATOR
Intervention: No contact (NC)
Number of subjects: 62
Study 22120032 — intervention group
Group type: COMPARATOR
Intervention: Force contact (FC)
Number of subjects: 62
Study 22120032 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Mobility (FM) scale
Number of subjects: 62
Study 19784445 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated nets (ITNs)
Number of subjects: 0
Study 19784445 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbial larvicides
Number of subjects: 0
Study 17130095 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicalutamide 150 mg/day
Number of subjects: 1218
Study 17130095 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone (placebo)
Number of subjects: 1218
Study 12627415 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 0
Study 12627415 — intervention group
Group type: COMPARATOR
Intervention: Open mesh surgery
Number of subjects: 0
Study 12383810 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency-Doubling Technology (FDT) perimetry
Number of subjects: 276
Study 12383810 — intervention group
Group type: EXPERIMENTAL
Intervention: Swedish Interactive Threshold Algorithm (SITA) perimetry
Number of subjects: 276
Study 9578182 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (400 ml)
Number of subjects: 8
Study 9578182 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 8
Study 7539183 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen withdrawal therapy
Number of subjects: 0
Study 7539183 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 0
Study 7539183 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7539183 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal therapy
Number of subjects: 0
Study 7539183 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate
Number of subjects: 0
Study 2533074 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (40 mg p.o.)
Number of subjects: 18
Study 2533074 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritanserin (10 mg p.o.)
Number of subjects: 18
Study 2533074 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 700249 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (1 gram per day for 4 weeks)
Number of subjects: 0
Study 700249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31028041 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow oxygenation by nasal cannula (HFNC)
Number of subjects: 186
Study 31028041 — intervention group
Group type: COMPARATOR
Intervention: Face mask preoxygenation
Number of subjects: 186
Study 28153353 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised magnesium sulphate (1ml of 15% magnesium sulphate + 1.5ml isotonic saline) with nebulised salbutamol (0.15mg/kg/dose)
Number of subjects: 100
Study 28153353 — intervention group
Group type: COMPARATOR
Intervention: Nebulised salbutamol (0.15mg/kg/dose) and 2.5ml isotonic saline (Placebo group)
Number of subjects: 100
Study 25279787 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose GQD (n=44)
Number of subjects: 187
Study 25279787 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate dose GQD (n=52)
Number of subjects: 187
Study 25279787 — intervention group
Group type: COMPARATOR
Intervention: Low dose GQD (n=50)
Number of subjects: 187
Study 25279787 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=41)
Number of subjects: 187
Study 23586537 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 'Different' trained on subsequences LLR, LRR, RLL, and RRL
Number of subjects: 0
Study 23586537 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 'Same' trained on subsequences LLL, LRL, RLR, and RRR
Number of subjects: 0
Study 23586537 — intervention group
Group type: COMPARATOR
Intervention: Control group trained on a pseudorandom ordering
Number of subjects: 0
Study 21679506 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic polyurethane foam (SPF)
Number of subjects: 64
Study 21679506 — intervention group
Group type: COMPARATOR
Intervention: Merocel
Number of subjects: 64
Study 20058593 — intervention group
Group type: EXPERIMENTAL
Intervention: Tecnis ZM900 MIOL (multifocal group)
Number of subjects: 114
Study 20058593 — intervention group
Group type: COMPARATOR
Intervention: Tecnis ZA9003 IOL (monofocal group)
Number of subjects: 114
Study 17098754 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of bone-marrow-derived progenitor cells (BMCs)
Number of subjects: 204
Study 17098754 — intervention group
Group type: COMPARATOR
Intervention: Placebo medium
Number of subjects: 204
Study 15071126 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet
Number of subjects: 741
Study 15071126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 741
Study 11297577 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) treatment for 18 months
Number of subjects: 40
Study 11297577 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 18 months
Number of subjects: 40
Study 9173675 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrolysin infusion (20 ml in 500 ml Ringer) for 10 days
Number of subjects: 20
Study 9173675 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vitamin B infusion 5 ml vitamin B complex in 500 ml Ringer) for 10 days
Number of subjects: 20
Study 8192292 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative overviews of randomized trials
Number of subjects: 0
Study 31518023 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 g CSO per ton
Number of subjects: 162
Study 31518023 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 g CSO per ton
Number of subjects: 162
Study 31518023 — intervention group
Group type: COMPARATOR
Intervention: Control (0 g CSO per ton)
Number of subjects: 162
Study 29897573 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir + lamivudine
Number of subjects: 92
Study 29897573 — intervention group
Group type: COMPARATOR
Intervention: Atazanavir/ritonavir + two NRTIs
Number of subjects: 92
Study 27914488 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month dual antiplatelet therapy (DAPT)
Number of subjects: 2700
Study 27914488 — intervention group
Group type: COMPARATOR
Intervention: 12 months or longer dual antiplatelet therapy (DAPT)
Number of subjects: 2700
Study 27914488 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month DAPT
Number of subjects: 2700
Study 27914488 — intervention group
Group type: COMPARATOR
Intervention: 12 months or longer DAPT
Number of subjects: 2700
Study 24440364 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonparetic arm force
Number of subjects: 9
Study 24440364 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 9
Study 24440364 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralesional to ipsilesional inhibition
Number of subjects: 9
Study 22390572 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin 100 U/mL
Number of subjects: 214
Study 22390572 — intervention group
Group type: COMPARATOR
Intervention: Saline flushes (control group)
Number of subjects: 214